Tidmarsh G F, Dailey M O, Whitlock C A, Pillemer E, Weissman I L
J Exp Med. 1985 Nov 1;162(5):1421-34. doi: 10.1084/jem.162.5.1421.
Animals injected with Abelson murine leukemia virus (A-MuLV) rapidly develop fatal bone marrow-derived lymphosarcomas. In all such diseased animals tested, a subpopulation of bone marrow cells expressed a monoclonal antibody-defined, B lineage transformation-associated antigen (6C3 Ag) at levels increased from that detected on normal lymphocytes. Cells bearing a high level of this antigen were found to be transformed as measured by clonal growth in agar, and they expressed surface antigen markers characteristic of early pre-B cells. High-level antigen-expressing cells were found in the bone marrow, lymph nodes, and spleen, but never in the thymus of diseased animals. This distribution agrees with the published pathology of Abelson disease.
注射了阿贝尔逊鼠白血病病毒(A-MuLV)的动物会迅速发展为致命的骨髓源性淋巴瘤。在所有检测的此类患病动物中,骨髓细胞亚群表达一种单克隆抗体定义的、与B系转化相关的抗原(6C3抗原),其水平高于正常淋巴细胞上检测到的水平。通过在琼脂中的克隆生长测定,发现携带高水平这种抗原的细胞已发生转化,并且它们表达早期前B细胞特有的表面抗原标志物。在患病动物的骨髓、淋巴结和脾脏中发现了高水平表达抗原的细胞,但在胸腺中从未发现。这种分布与已发表的阿贝尔逊病病理学一致。